Tag: AltaValve EFS

4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022

MINNEAPOLIS, May 19, 2022 /PRNewswire/ — 4C Medical Technologies, Inc. (“4C Medical” or the “Company”), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, presented its global clinical experience from its initial AltaValve Early Feasibility […]